Jennifer Bobolia

Dear Judiciary Committee Members, I am requesting that you vote OTP on HB 1292. Modeled precisely after a working Florida law, the bill lays out specific sectoral protections for regenerative stem cell usage. By prohibiting experimental treatment biotech companies from using stem cells of aborted children, companies can research life-saving treatments without supporting a life-taking industry. Stem cell treatments that do not use abortion will still be strongly protected. Companies in Florida are successfully using these protections, and New Hampshire should do the same. Thank you, Jennifer Bobolia, APRN